- Primary angle-closure glaucoma (PACG), a serious eye condition caused by a sudden or gradual blockage of the eye’s drainage channels, is becoming an increasingly critical focus in ophthalmic care due to its rapid progression and high risk of vision loss, especially in aging populations and genetically predisposed groups
- The rising demand for PACG management is primarily fueled by increasing global glaucoma awareness, enhanced access to diagnostic tools in emerging economies, and a growing geriatric population susceptible to elevated intraocular pressure
- North America dominated the primary angle-closure glaucoma market with the largest revenue share of 39.1% in 2024, supported by advanced healthcare infrastructure, favorable reimbursement policies, and increased uptake of laser-based and minimally invasive surgical treatments across the U.S. and Canada
- Asia-Pacific is expected to be the fastest growing region in the primary angle-closure glaucoma market during the forecast period due to expanding elderly populations, improved healthcare access, and national eye health programs, particularly in China, India, and Southeast Asia
- Chronic Angle-Closure Glaucoma dominated the primary angle-closure glaucoma market with a revenue share of 61.8% in 2024, owing to its higher prevalence, often asymptomatic progression, and increased detection through routine ophthalmic screening and awareness programs
